Hjem › Skleroderma › New York › New York City
Kliniske studier for Skleroderma i New York City, NY
11 studier for Skleroderma søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RekruttererFase 3
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekruttererFase 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruttererFase 2/3
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RekruttererFase 1/2
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
RekruttererFase 1
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekruttererFase 1
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
RekruttererFase 2
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RekruttererFase 2
- aTyr Investigative Site, New York
Skleroderma-studier i andre byer
- Ann Arbor, MI10 studier
- Chicago, IL10 studier
- Houston, TX9 studier
- Boston, MA7 studier
- Durham, NC7 studier
- Los Angeles, CA7 studier
- New Orleans, LA6 studier
- Philadelphia, PA6 studier
- Baltimore, MD6 studier
- Dallas, TX5 studier
- Pittsburgh, PA5 studier
- Plantation, FL4 studier
Andre studier i New York City
- Brystkreft134 studier
- Ikke-småcellet lungekreft120 studier
- Kreft (alle typer)110 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft77 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Pankreaskreft60 studier
- Multipelt myelom60 studier
- Endometriekreft52 studier
- Hjertesvikt51 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.